1. High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy
   Chaoqun Yang et al, 2014, Tumor Biology CrossRef
2. miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3
   ENJIE XU et al, 2016, Oncology Reports CrossRef
3. DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) inhibits chemotherapeutic drug-induced autophagy
   Yue Sheng et al, 2015, Acta Pharmaceutica Sinica B CrossRef
4. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances
   Xiu-guo Han et al, 2016, Tumor Biology CrossRef
5. 17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines
   M. Massimini et al, 2017, Veterinary Pathology CrossRef
6. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma
   Ren Chen et al, 2017, Molecular Medicine Reports CrossRef
7. Regulated cell death and drug resistance in malignant bone tumors
   Günther Richter et al, 2022, Bone Cancer CrossRef
8. The Regulatory Role of Non-coding RNA in Autophagy in Myocardial Ischemia-Reperfusion Injury
   Dan Wang et al, 2022, Frontiers in Pharmacology CrossRef
9. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
   Yu‑Xin Liao et al, 2019, International Journal of Oncology CrossRef
10. Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
    YANG QU et al, 2015, Oncology Reports CrossRef
11. Therapeutic effect of lymphokine-activated killer cells treated with low-dose ionizing radiation on osteosarcoma
    LEI ZHAO et al, 2015, Oncology Letters CrossRef
12. Genetic and Epigenetic Regulation of Autophagy in Cancer
    Anup S. Pathania et al, 2017, Genome Analysis and Human Health CrossRef
13. ATG14 facilitated lipophagy in cancer cells induce ER stress mediated mitoptosis through a ROS dependent pathway
    Subhadip Mukhopadhyay et al, 2017, Free Radical Biology and Medicine CrossRef
14. Role of autophagy in osteosarcoma
    Olivier Camuzard et al, 2019, Journal of Bone Oncology CrossRef
15. Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcoma
    Hong Toan Lai et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
16. 2-methylbenzoyl berbamine, a multi-targeted inhibitor, suppresses the growth of human osteosarcoma through disabling NF-κB, ERK and AKT signaling networks
    Weixu Li et al, 2020, Aging CrossRef
17. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance
    LI WANG et al, 2015, Oncology Reports CrossRef
18. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
    Cuiyun Li et al, 2018, International Journal of Molecular Medicine CrossRef
19. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
    Cally J. Ho et al, 2019, Cancers CrossRef
20. Role of microRNA-130a in myocardial hypoxia/reoxygenation injury
    Hongyan Liu et al, 2017, Experimental and Therapeutic Medicine CrossRef
21. A Genomewide Association Study Identifies Two Sex‐Specific Loci, at SPTB and IZUMO3, Influencing Pediatric Bone Mineral Density at Multiple Skeletal Sites
    Alessandra Chesi et al, 2017, Journal of Bone and Mineral Research CrossRef
22. Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex
    David Schlütermann et al, 2018, Urologic Oncology: Seminars and Original Investigations CrossRef